Thrive Capital Management (Pennsylvania)’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$471K Sell
1,087
-19
-2% -$5.77K 0.09% 131
2026
Q1
$236K Buy
+1,106
New +$247K 0.05% 159
2024
Q1
– Sell
-4,520
Closed -$354K – 171
2023
Q4
$354K Buy
4,520
+430
+11% +$29.3K 0.19% 84
2023
Q3
$257K Buy
4,090
+930
+29% +$61.1K 0.14% 111
2023
Q2
$203K Buy
+3,160
New +$178K 0.12% 134

Other funds holding LRCX

Thrive Capital Management (Pennsylvania)'s LRCX Position: Q2 2026 in Review

Thrive Capital Management (Pennsylvania) reduced its Lam Research (LRCX) stake by 1.7% in Q2 2026, selling an estimated $5.77K and leaving 1,087 shares worth $471K. The position accounts for 0.09% of the portfolio, ranked #131.

Thrive Capital Management (Pennsylvania) first reported a position in LRCX in Q2 2023 and has held it in 5 quarters since. 3,146 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Thrive Capital Management (Pennsylvania) held 1,087 shares of Lam Research worth $471K as of Q2 2026.
  • Thrive Capital Management (Pennsylvania) sold 19 Lam Research shares in Q2 2026, an estimated $5.77K.
  • Lam Research made up 0.09% of Thrive Capital Management (Pennsylvania)'s portfolio in Q2 2026, its #131 holding.
  • Thrive Capital Management (Pennsylvania) first reported a position in Lam Research in Q2 2023 and has held it in 5 quarters since.
  • 3,146 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q2 2026, filed 5 Aug 2026.